Intercalary Diaphyseal Endoprosthetic Reconstruction.

J Am Acad Orthop Surg Glob Res Rev · Jul 01 2025 · Review

Damron TA, Malhotra A

From the Department of Orthopedic Surgery, SUNY Upstate Medical University (Dr. Damron), and the Norton College of…

Orthopaedic Trauma Orthopaedic Oncology

SUMMARY — THE REDUCTIONReview of intercalary diaphyseal endoprostheses for tumors and metastases covers designs, indications, alternatives, and results; function and complications are acceptable, but aseptic loosening remains a leading cause of failure.
Abstract, as published

Intercalary endoprosthetic devices are a diaphyseal segmental reconstructive option for both primary tumors and skeletal metastases, most used for pathological fractures or failure of internal fixation. Numerous designs have been employed with varying success. These implants require adequate quality and length bone stock, both proximal and distal, to be employed. Alternative reconstructions may include vascularized fibula autograft, allograft reconstruction, acute shortening, and fixation with cement spacer augmentation with planning staged procedures. The reported functional results and complication profile of intercalary endoprostheses are acceptable, but their use is carefully considered, as aseptic loosening remains one of the most common risks for failure. Although successful at short follow-up, these devices are often used for patients with segmental destruction or tumor involvement of the upper extremity, particularly in cases with metastatic bone disease or myeloma. In this review, we discuss the numerous designs, indications and contraindications, alternative options, biomechanics, reported results, and complications.

Featured in the 2026-10-11 issue.

← An Update on Osteoporosis Screening: Advances, Applications, …Distal Radius Fractures: Classifications and Contemporary Tre… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.